clinicaltrialsarena5h
FDA lifts hold on Opella’s trial to support switch of Cialis to OTC drug
The US FDA has removed the clinical hold on a trial of Cialis (tadalafil) by Sanofi's consumer healthcare business, Opella.
Mediafeed on MSN9mon
Cialis 20 mg: What You Need to Know Before Starting It
You might have seen Cialis® — the erectile dysfunction (ED) drug — available in doses ranging from 2.5 mg to 20 mg. Surely, ...
Sanofi says FDA lifted clinical hold on trial for Cialis OTC switch
Sanofi’s (NASDAQ:SNY) consumer healthcare unit Opella announced Tuesday that the U.S. FDA has lifted a clinical hold on a ...
FiercePharma23h
Sanofi's consumer health arm Opella secures FDA green light to pursue OTC Cialis study
After hitting a regulatory roadblock in 2022, Sanofi’s consumer healthcare business Opella has secured the FDA’s blessing to ...
The Pharma Letter1d
Sanofi reaches study milestone for Cialis
French pharma major Sanofi’s consumer healthcare business, Opella, has announced that the US Food and Drug Administration ...
AOL22d
Cialis Side Effects: What to Expect (& How to Avoid Them)
Headaches can still be common for those who take a lower 10-milligram dose of Cialis, affecting about 12 percent of men. Most of the time, Cialis-induced headaches are mild and become less intense ...
Sanofi's Opella: FDA Lifts Clinical Hold On OTC Cialis Trial
Sanofi's Consumer Healthcare division, Opella, announced that the U.S. Food and Drug Administration has lifted a clinical hold on its ...
Press Release: Opella reaches study milestone for Cialis
Opella reaches study milestone for CialisParis, January 21, 2025. Opella, Sanofi’s Consumer Healthcare business, announced that the US Food and ...